Muscle volume loss after the induction of first-line chemotherapy as a novel prognostic factor in metastatic colorectal cancer patients

被引：0

作者：

Yoshikawa, Yusuke ^{[1
]}

Okabayashi, Koji ^{[1
]}

Hasegawa, Hirotoshi ^{[1
]}

Tsuruta, Masashi ^{[1
]}

Seishima, Ryo ^{[1
]}

Takahashi, Hidena ^{[1
]}

Yamada, Toru ^{[1
]}

Matsui, Shimpei ^{[1
]}

Kondo, Takayuki ^{[1
]}

Shimada, Takehiro ^{[1
]}

Matsuda, Mutsuhito ^{[1
]}

Yahagi, Masashi ^{[1
]}

Asada, Yusuke ^{[1
]}

Sugiura, Kiyoaki ^{[1
]}

Suzuki, Yoshiyuki ^{[1
]}

Tajima, Yuki ^{[1
]}

Nakadai, Junpei ^{[1
]}

Kitagawa, Yuko ^{[1
]}

机构：

[1] Keio Univ, Sch Med, Dept Surg, Tokyo 160, Japan

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 03期

关键词：

D O I：

10.1200/jco.2015.33.3_suppl.558

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

558

引用

页数：1

共 50 条

[41] The prognostic impact of NKA dynamics in first-line treatment of metastatic colorectal cancer
Nederby, Line
Raunkilde, Louise
Jakobsen, Anders
Jensen, Lars Henrik
Havelund, Birgitte Mayland
Wen, Sara Witting Christensen
Hansen, Torben
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[42] Optimizing the Efficacy of First-Line Chemotherapy plus Bevacizumab in Metastatic Colorectal Cancer
Shaotang Li
Pan Dr Chi
BioDrugs, 2011, 25 : 43 - 50
[43] When to Use Triplet Chemotherapy as First-Line Treatment in Metastatic Colorectal Cancer
Cremolini, Chiara
CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (08) : 433 - 435
[44] SAFETY AND EFFICACY OF BEVACIZUMAB PLUS STANDARD FIRST-LINE CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER: FIRST BEAT
Van Cutsem, E.
Berry, S.
Michael, M.
Kretzschmar, A.
Rivera, F.
DiBartolomeo, M.
Mazier, M.
Andre, N.
Cunningham, D.
ANNALS OF ONCOLOGY, 2008, 19 : 125 - 125
[45] NICE guidance on cetuximab, bevacizumab, and panitumumab for treatment of metastatic colorectal cancer after first-line chemotherapy
Rinaldi, Fiona
George, Elisabeth
Adler, Amanda I.
LANCET ONCOLOGY, 2012, 13 (03): : 233 - 234
[46] SECOND-LINE TREATMENTS IN PATIENTS WITH METASTATIC COLORECTAL CANCER PROGRESSED AFTER FIRST-LINE FOLFOXIRI
Fornaro, Lorenzo
Vasile, Enrico
Masi, Gianluca
Loupakis, Fotios
Salvatore, Lisa
Stasi, Irene
Baldi, Giacomo Giulio
Cupini, Samanta
Barbara, Cecilia
Pfanner, Elisabetta
Brunetti, Isa Maura
Di Donato, Samantha
Caponi, Sara
Allegrini, Giacomo
Antonuzzo, Andrea
Ricci, Sergio
Chiara, Silvana
Vitello, Stefano
Andreuccetti, Michele
Falcone, Alfredo
ANNALS OF ONCOLOGY, 2009, 20
[47] Second-line treatments in patients with metastatic colorectal cancer progressed after first-line FOLFOXIRI
Masi, G.
Vasile, E.
Loupakis, F.
Fornaro, L.
Salvatore, L.
Cupini, S.
Stasi, I.
Brunetti, I. M.
Andreuccetti, M.
Falcone, A.
EJC SUPPLEMENTS, 2009, 7 (02): : 346 - 347
[48] Negative impact of cachexia during chemotherapy on survival as first-line chemotherapy for metastatic colorectal cancer
Nozawa, Kazuki
Masuishi, Toshiki
Kumanishi, Ryosuke
Nakazawa, Taiko
Ogata, Takatsugu
Matsubara, Yuki
Kato, Kyoko
Narita, Yukiya
Honda, Kazunori
Bando, Hideaki
Kadowaki, Shigenori
Andoh, Masashi
Tajika, Masahiro
Muro, Kei
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[49] Neurotoxicity as a Prognostic Factor in Patients with Metastatic Breast Cancer Treated with Ixabepilone as a First-Line Therapy
Durando, Xavier
Dalenc, Florence
Abrial, Catherine
Mouret-Reynier, Marie-Ange
Herviou, Pauline
Kwiatkowski, Fabrice
Chollet, Philippe
Roche, Henri
Thivat, Emilie
ONCOLOGY, 2015, 88 (03) : 180 - 188
[50] Is the prognostic nutritional index a prognostic and predictive factor in metastatic non-small cell lung cancer patients treated with first-line chemotherapy?
Yakup Bozkaya
Osman Köstek
Abdullah Sakin
Deniz Tataroğlu Özyükseler
Teoman Şakalar
İbrahim Çil
Supportive Care in Cancer, 2020, 28 : 2273 - 2282

← 1 2 3 4 5 →